The cost of ignoring employee stress is high—from absenteeism to quiet quitting and turnover. Proactive support, on the other ...

OSE Immunotherapeutics, chef de file d’un consortium français aux côtés d’Inside Therapeutics et du laboratoire MiNT (Université d’Angers), obtient un financement de 1,3 million d’euros de Bpifrance ...

Pyzchiva® is a key biosimilar value driver for the Sandoz growth strategy. It has been launched in 23 markets in Europe. The autoinjector is now available in Spain and will continue to roll out across ...

CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announces a strategic collaboration with Angoulême/Bordeaux- based Inside Therapeutics and Angers-based MiNT Laboratory to ...

Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional ...

PHM23 was one of a handful of molecules chosen by the university; Bird Flu helping PHM23 gain awareness of broad-spectrum activity at a university level; BOSTON, MASSACHUSETTS, Ma ...

A fireside chat at the TD Cowen: 6th Annual Oncology Innovation Summit at 9:30 a.m. ET on Wednesday, May 28, 2025. A live webcast will be available using this weblink: https://wsw.com/webcast/cowen180 ...

The Company is currently conducting two additional SPC-15 studies: an IND-enabling GLP (Good Laboratory Practice)-compliant toxicology and toxicokinetics study, and an FDA requested 7-day safety and ...

The Phase 1/2 clinical trial ( NCT06810544) is evaluating the safety, pharmacokinetics, pharmacodynamics and antitumor activity of TNG456 as a monotherapy and in combination with abemaciclib. We are ...

Agency supports primary and novel secondary and exploratory endpoints proposed for Phase 3 Trial(s) Opportunity to utilize time-to-delay of levodopa/carbidopa initiation as an end ...

REDWOOD CITY, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...

To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at A replay of the fireside chat will be available on the Ardelyx ...